CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma [published correction appears in J Hepatol. 2019 Apr;70(4):817]. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.019
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–1022. doi:10.1002/hep.24199
   PubMed Web of Science ®Google Scholar
• European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma [published correction appears in J Hepatol. 2012 Jun;56(6):1430]. J Hepatol. 2012;56(4):908–943. doi:10.1016/j.jhep.2011.12.001
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380. doi:10.1002/hep.29086
   PubMed Web of Science ®Google Scholar
• Zhuang L, Wu Y, Han J, et al. A network biology approach to discover the molecular biomarker associated with hepatocellular carcinoma. Biomed Res Int. 2014;2014:278956. doi:10.1155/2014/278956
   PubMed Web of Science ®Google Scholar
• Chow EY, Zhang J, Qin H, Chan TF. Characterization of hepatocellular carcinoma cell lines using a fractionation-then-sequencing approach reveals nuclear-enriched HCC-associated lncRNAs. Front Genet. 2019;10:1081. doi:10.3389/fgene.2019.01081
   PubMed Web of Science ®Google Scholar
• Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604. doi:10.1038/s41575-019-0186-y
   PubMed Web of Science ®Google Scholar
• Kim H-S, El-Serag HB. The epidemiology of hepatocellular carcinoma in the USA. Curr Gastroenterol Rep. 2019;21(4):17. doi:10.1007/s11894-019-0681-x
   PubMedGoogle Scholar
• Wu M, Liu Z, Li X, Zhang A, Lin D, Li N. Analysis of potential key genes in very early hepatocellular carcinoma. World J Surg Oncol. 2019;17(1):77. doi:10.1186/s12957-019-1616-6
   PubMed Web of Science ®Google Scholar
• Yin F, Shu L, Liu X, et al. Microarray-based identification of genes associated with cancer progression and prognosis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2016;35(1):127. doi:10.1186/s13046-016-0403-2
   PubMed Web of Science ®Google Scholar
• Li R, Jiang X, Zhang Y, et al. Cyclin B2 overexpression in human hepatocellular carcinoma is associated with poor prognosis. Arch Med Res. 2019;50(1):10–17. doi:10.1016/j.arcmed.2019.03.003
   PubMed Web of Science ®Google Scholar
• Li J, Gao JZ, Du JL, Huang ZX, Wei LX. Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma. Int J Oncol. 2014;45(4):1547–1555. doi:10.3892/ijo.2014.2559
   PubMed Web of Science ®Google Scholar
• Chen C, Song G, Xiang J, Zhang H, Zhao S, Zhan Y. AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma. Biochem Biophys Res Commun. 2017;486(2):514–520. doi:10.1016/j.bbrc.2017.03.075
   PubMed Web of Science ®Google Scholar
• Zhu LF, Hu Y, Yang CC, et al. Snail overexpression induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells. Lab Invest. 2012;92(5):744–752. doi:10.1038/labinvest.2012.8
   PubMed Web of Science ®Google Scholar
• Varga Z, Moelans CB, Zuerrer-Hardi U, et al. Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes. Breast Cancer Res Treat. 2012;133:929–935.
   PubMed Web of Science ®Google Scholar
• Panvichian R, Tantiwetrueangdet A, Angkathunyakul N, Leelaudomlipi S. TOP2A amplification and overexpression in hepatocellular carcinoma tissues. Biomed Res Int. 2015;2015:381602. doi:10.1155/2015/381602
   PubMed Web of Science ®Google Scholar
• Wong N, Yeo W, Wong WL, et al. TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance. Int J Cancer. 2009;124(3):644–652. doi:10.1002/ijc.23968
   PubMed Web of Science ®Google Scholar
• Xia H, Kong SN, Chen J, et al. MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence. Cancer Lett. 2016;383(1):85–93. doi:10.1016/j.canlet.2016.09.017
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao B, Tan PY, et al. Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth. FASEB J. 2019;33(8):8759–8770. doi:10.1096/fj.201802213RR
   PubMed Web of Science ®Google Scholar
• Zhang Q, Su R, Shan C, Gao C, Wu P. Non-SMC condensin I complex, subunit G (NCAPG) is a novel mitotic gene required for hepatocellular cancer cell proliferation and migration. Oncol Res. 2018;26(2):269–276. doi:10.3727/096504017X15075967560980
   PubMed Web of Science ®Google Scholar
• Gasnereau I, Boissan M, Margall-Ducos G, et al. KIF20A mRNA and its product MKlp2 are increased during hepatocyte proliferation and hepatocarcinogenesis. Am J Pathol. 2012;180(1):131–140. doi:10.1016/j.ajpath.2011.09.040
   PubMed Web of Science ®Google Scholar
• Lu M, Huang X, Chen Y, et al. Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma. IUBMB Life. 2018;70(4):328–335. doi:10.1002/iub.1726
   PubMed Web of Science ®Google Scholar
• Guo L, Ding Z, Huang N, Huang Z, Zhang N, Xia Z. Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death. Cell Cycle. 2017;16(18):1705–1718. doi:10.1080/15384101.2017.1356507
   PubMed Web of Science ®Google Scholar
• Xiong Y, Lu J, Fang Q, et al. UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells. Biosci Rep. 2019;39(4):BSR20182384. doi:10.1042/BSR20182384
   PubMed Web of Science ®Google Scholar
• Rao S, Xiang J, Huang J, et al. PRC1 promotes GLI1-dependent osteopontin expression in association with the Wnt/β-catenin signaling pathway and aggravates liver fibrosis. Cell Biosci. 2019;9:100. doi:10.1186/s13578-019-0363-2
   PubMed Web of Science ®Google Scholar
• Chen J, Rajasekaran M, Xia H, et al. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway. Gut. 2016;65(9):1522–1534. doi:10.1136/gutjnl-2015-310625
   PubMed Web of Science ®Google Scholar
• Tang H, Zhao H, Yu ZY, et al. MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/β-catenin signaling pathway. Dig Liver Dis. 2019;51(9):1314–1322. doi:10.1016/j.dld.2019.02.012
   PubMedGoogle Scholar
• Wu SC, Chang SC, Wu HY, Liao PJ, Chang MF. Hepatitis C virus NS5A protein down-regulates the expression of spindle gene Aspm through PKR-p38 signaling pathway. J Biol Chem. 2008;283(43):29396–29404. doi:10.1074/jbc.M802821200
   PubMed Web of Science ®Google Scholar
• Gai M, Bianchi FT, Vagnoni C, et al. ASPM and CITK regulate spindle orientation by affecting the dynamics of astral microtubules [published correction appears in EMBO Rep. 2017 Oct;18(10):1870]. EMBO Rep. 2016;17(10):1396–1409. doi:10.15252/embr.201541823
   PubMed Web of Science ®Google Scholar